Skip to content

Clinical trial of the effect of honeybee larvae production on the hearing ability

Clinical trial of the effect of honeybee larvae production on the hearing ability - Honeybee larvae study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034706
Enrollment
60
Registered
2018-12-01
Start date
2018-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sensorineural hearing loss

Interventions

Intervention period (12 weeks), mount of intervention food (honeybee larvae 180mg x 4 tablets/day Intervention period (12 weeks), placebo 4 tablets/day

Sponsors

Gifu Univesity School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. no perforation of the drum 2. mild bilateral sensorineural hearing loss (26-40dB) or moderate bilateral sensorineural hearing loss (41-60 dB) 3. subjective tinnitus of unilateral or bilateral ear 4. well understand the objective of this study

Exclusion criteria

Exclusion criteria: 1. subjects who already have had honeybee larave 2. active ottis media 3. acute hearing loss 4. apparent inner ear disease such as Meniere's disease 5. subjects who have received the treatment for hearing loss 6. allergy of the food 7. digestive dysfucntion of the honeybee larave products 8. cerebral vascular disease 9. blood donor within these 4 weeks 10. alcohol or drug dependence syndrome 11. subjects who had attended another clinical trial within 3 months 12. subjects living with teh house mate who attend this study 13. subjects who do not comply the rulr of this study 14. subject who are pointed out as nscreened personnel

Design outcomes

Primary

MeasureTime frame
Change of the hearing level on audiometry

Secondary

MeasureTime frame
Hearing Handicap Inventory for elderly,,Geriatric depression score,Chalder fatigue scale,, speech discrimination under noise, blood findings(IL2R, IL6,IL12,HDLC,LDLC,oxidative LDL,NO,DHEAS,HbA1c,adiponectine,SIRT1/3,Cre,UA,eGF,S1P)

Countries

Japan

Contacts

Public ContactMitsuhiro Aoki

GIfu university Hospital Department of Otolaryngology

aoki@gifu-u.ac.jp0582306279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026